Ralf Uebelhack

1.6k total citations
69 papers, 1.2k citations indexed

About

Ralf Uebelhack is a scholar working on Psychiatry and Mental health, Pharmacology and Physiology. According to data from OpenAlex, Ralf Uebelhack has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 10 papers in Pharmacology and 9 papers in Physiology. Recurrent topics in Ralf Uebelhack's work include Tryptophan and brain disorders (8 papers), Diet and metabolism studies (6 papers) and Eating Disorders and Behaviors (6 papers). Ralf Uebelhack is often cited by papers focused on Tryptophan and brain disorders (8 papers), Diet and metabolism studies (6 papers) and Eating Disorders and Behaviors (6 papers). Ralf Uebelhack collaborates with scholars based in Germany, United States and Switzerland. Ralf Uebelhack's co-authors include L. Franke, Joerg Gruenwald, B. Müller‐Oerlinghausen, Margret I. Moré, Martin Schaefer, Andreas Heinz, Markus Schwaiger, Florian van Bömmel, M.G.L. Pich and Thomas Berg and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Journal of Hepatology.

In The Last Decade

Ralf Uebelhack

66 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralf Uebelhack Germany 19 236 182 151 146 144 69 1.2k
Shahram Ejtemaei Mehr Iran 26 125 0.5× 417 2.3× 32 0.2× 421 2.9× 211 1.5× 70 1.9k
Yosefa Avraham Israel 27 77 0.3× 407 2.2× 167 1.1× 330 2.3× 724 5.0× 54 1.8k
Paul Demedts Belgium 17 355 1.5× 156 0.9× 111 0.7× 212 1.5× 161 1.1× 33 2.1k
Frederico C. Pereira Portugal 23 67 0.3× 481 2.6× 46 0.3× 352 2.4× 90 0.6× 76 1.5k
Danièle Bentué‐Ferrer France 23 217 0.9× 348 1.9× 32 0.2× 224 1.5× 361 2.5× 131 1.7k
Xiaohui Xu China 24 307 1.3× 122 0.7× 76 0.5× 433 3.0× 76 0.5× 64 1.7k
Mohammad Ali Azarbayjani Iran 20 63 0.3× 103 0.6× 34 0.2× 324 2.2× 157 1.1× 220 1.8k
Jason Nguyen Australia 10 121 0.5× 113 0.6× 76 0.5× 363 2.5× 68 0.5× 12 1.4k
Sarah Aldred United Kingdom 28 231 1.0× 87 0.5× 60 0.4× 443 3.0× 93 0.6× 73 2.2k
Prasanta Dey India 27 92 0.4× 290 1.6× 38 0.3× 539 3.7× 155 1.1× 54 1.9k

Countries citing papers authored by Ralf Uebelhack

Since Specialization
Citations

This map shows the geographic impact of Ralf Uebelhack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralf Uebelhack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralf Uebelhack more than expected).

Fields of papers citing papers by Ralf Uebelhack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralf Uebelhack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralf Uebelhack. The network helps show where Ralf Uebelhack may publish in the future.

Co-authorship network of co-authors of Ralf Uebelhack

This figure shows the co-authorship network connecting the top 25 collaborators of Ralf Uebelhack. A scholar is included among the top collaborators of Ralf Uebelhack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralf Uebelhack. Ralf Uebelhack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Forssten, Sofia D., Alvin Ibarra, Jouni Junnila, et al.. (2022). Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials. American Journal of Clinical Nutrition. 116(6). 1580–1594. 9 indexed citations
3.
Moré, Margret I., et al.. (2019). A Dose-Escalation Study Demonstrates the Safety and Tolerability of Cellobiose in Healthy Subjects. Nutrients. 12(1). 64–64. 5 indexed citations
4.
Gruenwald, Joerg, Ralf Uebelhack, & Margret I. Moré. (2019). Rosa canina – Rose hip pharmacological ingredients and molecular mechanics counteracting osteoarthritis – A systematic review. Phytomedicine. 60. 152958–152958. 38 indexed citations
5.
6.
Uebelhack, Ralf, et al.. (2016). Double-blind, randomized, placebo-controlled, bicentric clinical investigation to evaluate the benefit and tolerability of Redusure IQP-AK-102 in reducing body weight in overweight and obese subjects. 4(3). 73–82.
7.
Grube, Barbara, et al.. (2015). Weight Maintenance with Litramine (IQP-G-002AS): A 24-Week Double-Blind, Randomized, Placebo-Controlled Study. Journal of Obesity. 2015. 1–6. 10 indexed citations
8.
Gruenwald, Joerg, et al.. (2014). A Review of the Efficacy and Safety of Litramine IQP‐G‐002AS, an Opuntia ficus-indica Derived Fiber for Weight Management. Evidence-based Complementary and Alternative Medicine. 2014(1). 943713–943713. 19 indexed citations
9.
Holinski, Sebastian, et al.. (2012). Effect of Different Pump Heads for CPB on Early Cognitive Outcome after Coronary Artery Bypass Surgery. Annals of Thoracic and Cardiovascular Surgery. 19(4). 273–278. 3 indexed citations
10.
Holinski, Sebastian, et al.. (2012). Transfemoral Versus Conventional Aortic Valve Implantation^|^#8212; Early Postoperative Cognitive Outcome ^|^#8212;. Annals of Thoracic and Cardiovascular Surgery. 19(3). 195–200. 11 indexed citations
11.
Franke, L., et al.. (2009). Serotonin transporter activity and serotonin concentration in platelets of patients with irritable bowel syndrome: effect of gender. Journal of Gastroenterology. 45(4). 389–398. 26 indexed citations
12.
Schaefer, Martin, Jochen Winterer, Rahul Sarkar, et al.. (2008). Three Cases of Successful Tryptophan Add-On or Monotherapy of Hepatitis C and IFNα-Associated Mood Disorders. Psychosomatics. 49(5). 442–446. 12 indexed citations
13.
Ehrlich, Stefan, L. Franke, Nora Schneider, et al.. (2008). Aromatic amino acids in weight‐recovered females with anorexia nervosa. International Journal of Eating Disorders. 42(2). 166–172. 21 indexed citations
14.
Ehrlich, Stefan, Harriet Salbach‐Andrae, Deike Weiss, et al.. (2008). S100B in underweight and weight-recovered patients with anorexia nervosa. Psychoneuroendocrinology. 33(6). 782–788. 18 indexed citations
15.
Ehrlich, Stefan, L. Franke, Harriet Salbach‐Andrae, et al.. (2008). Platelet Monoamine Oxidase Activity in Underweight and Weight-Recovered Females with Anorexia Nervosa. Pharmacopsychiatry. 41(6). 226–231. 12 indexed citations
16.
Schaefer, Martin, Markus Schwaiger, M.G.L. Pich, et al.. (2005). Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. Journal of Hepatology. 42(6). 793–798. 139 indexed citations
17.
Franke, L., et al.. (2003). Platelet-5HT uptake and gastrointestinal symptoms in patients suffering from major depression. Life Sciences. 74(4). 521–531. 8 indexed citations
18.
Grunze, Heinz, J. Walden, Sandra Dittmann, et al.. (2002). Psychopharmakotherapie bipolarer affektiver Erkrankungen. Der Nervenarzt. 73(1). 4–19. 14 indexed citations
19.
Kaiser, Rolf, J. Schmider, Maren Henneken, et al.. (2001). Serotonin transporter polymorphisms: no association with response to antipsychotic treatment, but associations with the schizoparanoid and residual subtypes of schizophrenia. Molecular Psychiatry. 6(2). 179–185. 73 indexed citations
20.
Uebelhack, Ralf, et al.. (1998). Inhibition of Platelet MAO-B by Kava Pyrone-Enriched Extract from Piper Methysticum Forster (Kava-Kava). Pharmacopsychiatry. 31(5). 187–192. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shahram Ejtemaei Mehr Breakdown of academic impact, for papers by Yosefa Avraham Breakdown of academic impact, for papers by Paul Demedts Breakdown of academic impact, for papers by Frederico C. Pereira Breakdown of academic impact, for papers by Danièle Bentué‐Ferrer Breakdown of academic impact, for papers by Xiaohui Xu Breakdown of academic impact, for papers by Mohammad Ali Azarbayjani Breakdown of academic impact, for papers by Jason Nguyen Breakdown of academic impact, for papers by Sarah Aldred Breakdown of academic impact, for papers by Prasanta Dey
Rankless by CCL
2026